位置:首页 > 蛋白库 > CLD15_MOUSE
CLD15_MOUSE
ID   CLD15_MOUSE             Reviewed;         227 AA.
AC   Q9Z0S5; Q9D7Z0; Q9D8A6;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   10-MAY-2002, sequence version 2.
DT   03-AUG-2022, entry version 142.
DE   RecName: Full=Claudin-15;
GN   Name=Cldn15;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J; TISSUE=Small intestine, and Stomach;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J; TISSUE=Mammary gland;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-122.
RC   TISSUE=Lung;
RA   Morita K., Furuse M., Tsukita S.;
RL   Submitted (FEB-1999) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   TISSUE SPECIFICITY.
RX   PubMed=16505581; DOI=10.1679/aohc.68.349;
RA   Inai T., Sengoku A., Guan X., Hirose E., Iida H., Shibata Y.;
RT   "Heterogeneity in expression and subcellular localization of tight junction
RT   proteins, claudin-10 and -15, examined by RT-PCR and immunofluorescence
RT   microscopy.";
RL   Arch. Histol. Cytol. 68:349-360(2005).
RN   [5]
RP   DISRUPTION, FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=18242218; DOI=10.1053/j.gastro.2007.11.040;
RA   Tamura A., Kitano Y., Hata M., Katsuno T., Moriwaki K., Sasaki H.,
RA   Hayashi H., Suzuki Y., Noda T., Furuse M., Tsukita S., Tsukita S.;
RT   "Megaintestine in claudin-15-deficient mice.";
RL   Gastroenterology 134:523-534(2008).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-214 AND SER-217, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brown adipose tissue, and Kidney;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
RN   [7]
RP   FUNCTION, DISRUPTION PHENOTYPE, SUBCELLULAR LOCATION, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=20727355; DOI=10.1053/j.gastro.2010.08.006;
RA   Tamura A., Hayashi H., Imasato M., Yamazaki Y., Hagiwara A., Wada M.,
RA   Noda T., Watanabe M., Suzuki Y., Tsukita S.;
RT   "Loss of claudin-15, but not claudin-2, causes Na+ deficiency and glucose
RT   malabsorption in mouse small intestine.";
RL   Gastroenterology 140:913-923(2011).
RN   [8]
RP   DISRUPTION PHENOTYPE, FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=23089202; DOI=10.1053/j.gastro.2012.10.035;
RA   Wada M., Tamura A., Takahashi N., Tsukita S.;
RT   "Loss of claudins 2 and 15 from mice causes defects in paracellular Na+
RT   flow and nutrient transport in gut and leads to death from malnutrition.";
RL   Gastroenterology 144:369-380(2013).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) OF 1-194 OF MUTANT
RP   ALA-102/ALA-183/ALA-184/ALA-185, SUBCELLULAR LOCATION, SUBUNIT, MUTAGENESIS
RP   OF MET-68; CYS-102; 146-PHE-PHE-147 AND 183-CYS--CYS-185, TOPOLOGY,
RP   DISULFIDE BOND, AND PALMITOYLATION.
RX   PubMed=24744376; DOI=10.1126/science.1248571;
RA   Suzuki H., Nishizawa T., Tani K., Yamazaki Y., Tamura A., Ishitani R.,
RA   Dohmae N., Tsukita S., Nureki O., Fujiyoshi Y.;
RT   "Crystal structure of a claudin provides insight into the architecture of
RT   tight junctions.";
RL   Science 344:304-307(2014).
CC   -!- FUNCTION: Claudins function as major constituents of the tight junction
CC       complexes that regulate the permeability of epithelia. While some
CC       claudin family members function as impermeable barriers, others mediate
CC       the permeability to ions and small molecules. Often, several claudin
CC       family members are coexpressed and interact with each other, and this
CC       determines the overall permeability. CLDN15 forms tight junctions that
CC       mediate the paracellular transport of small monovalent cations along a
CC       concentration gradient, due to selective permeability for Na(+), Li(+)
CC       and K(+) ions, but selects against Cl(-) ions. Plays an important role
CC       in paracellular Na(+) transport in the intestine and in Na(+)
CC       homeostasis. Required for normal Na(+)-dependent intestinal nutrient
CC       uptake. {ECO:0000269|PubMed:18242218, ECO:0000269|PubMed:20727355,
CC       ECO:0000269|PubMed:23089202}.
CC   -!- SUBUNIT: Can form linear homooligomers in the membrane, giving rise to
CC       tight junction strand-like structures. {ECO:0000269|PubMed:24744376}.
CC   -!- SUBCELLULAR LOCATION: Cell junction, tight junction. Cell membrane;
CC       Multi-pass membrane protein. Note=Tight junctions form continuous
CC       circumferential cell-cell contacts at the borders of apical and lateral
CC       cell membranes that seal the intercellular space and show up as strand-
CC       like structures in electron microscopy.
CC   -!- TISSUE SPECIFICITY: Detected in duodenum, jejunum and ileum. Detected
CC       on intestinal villi and crypts (at protein level). Ubiquitous. Detected
CC       in small intestine, colon, jejunum, heart, kidney and lung.
CC       {ECO:0000269|PubMed:16505581, ECO:0000269|PubMed:18242218,
CC       ECO:0000269|PubMed:20727355, ECO:0000269|PubMed:23089202}.
CC   -!- PTM: Palmitoylated when heterogeneously expressed in S.frugiperda
CC       cells. {ECO:0000269|PubMed:24744376}.
CC   -!- DISRUPTION PHENOTYPE: No visible phenotype at birth and during the
CC       first four weeks after birth. After about eight weeks, the upper part
CC       of the small intestine is abnormally increased both in length and in
CC       thickness with enlarged villi and crypts. The villi are about two times
CC       larger than normal, and each is associated with about forty abnormally
CC       large crypts instead of the normally observed ratio of ten crypts per
CC       villus. In contrast, there is no difference in the size of the lower
CC       part of the small intestine. The body weight of mutant mice does not
CC       differ from that of wild-type littermates (PubMed:18242218). According
CC       to PubMed:20727355, the intestinal mucosa from newborn and adult mutant
CC       mice displays strongly decreased transepithelial conductance with
CC       strongly reduced paracellular Na(+) permeability, but no major changes
CC       in paracellular permeability to Cl(-). Adults show strongly decreased
CC       Na(+) levels in the lumen of the small intestine. Mutant mice also
CC       display decreased intestinal glucose uptake, probably due to decreased
CC       Na(+) levels. According to PubMed:23089202, mutant mice lacking both
CC       Cldn2 and Cldn15 display no visible phenotype at birth, but show
CC       decreased growth after about 10 days, severe developmental retardation
CC       about 14 days after birth, and then die from malnutrition. None survive
CC       more than 25 days after birth. Mice lacking both Cldn2 and Cldn15 show
CC       abnormally low Na(+) levels in the intestine, leading to decreased
CC       intestinal glucose uptake; glucose uptake can be restored to normal
CC       levels by addition of Na(+). Likewise, mice lacking both Cldn2 and
CC       Cldn15 show decreased intestinal uptake of milk fat, fatty acids, bile
CC       acids and amino acids; again, normal bile acid and amino acid uptake
CC       can be restored by the addition of Na(+). {ECO:0000269|PubMed:18242218,
CC       ECO:0000269|PubMed:20727355, ECO:0000269|PubMed:23089202}.
CC   -!- SIMILARITY: Belongs to the claudin family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK008227; BAB25544.1; -; mRNA.
DR   EMBL; AK008683; BAB25831.1; -; mRNA.
DR   EMBL; BC023428; AAH23428.1; -; mRNA.
DR   EMBL; AF124427; AAD17331.1; -; mRNA.
DR   CCDS; CCDS19758.1; -.
DR   RefSeq; NP_068365.1; NM_021719.4.
DR   PDB; 4P79; X-ray; 2.40 A; A=2-194.
DR   PDBsum; 4P79; -.
DR   AlphaFoldDB; Q9Z0S5; -.
DR   SMR; Q9Z0S5; -.
DR   STRING; 10090.ENSMUSP00000106722; -.
DR   TCDB; 1.H.1.1.12; the claudin tight junction (claudin1) family.
DR   iPTMnet; Q9Z0S5; -.
DR   PhosphoSitePlus; Q9Z0S5; -.
DR   MaxQB; Q9Z0S5; -.
DR   PaxDb; Q9Z0S5; -.
DR   PeptideAtlas; Q9Z0S5; -.
DR   PRIDE; Q9Z0S5; -.
DR   ProteomicsDB; 283578; -.
DR   Antibodypedia; 16744; 201 antibodies from 21 providers.
DR   DNASU; 60363; -.
DR   Ensembl; ENSMUST00000001790; ENSMUSP00000001790; ENSMUSG00000001739.
DR   Ensembl; ENSMUST00000111093; ENSMUSP00000106722; ENSMUSG00000001739.
DR   GeneID; 60363; -.
DR   KEGG; mmu:60363; -.
DR   UCSC; uc009abg.2; mouse.
DR   CTD; 24146; -.
DR   MGI; MGI:1913103; Cldn15.
DR   VEuPathDB; HostDB:ENSMUSG00000001739; -.
DR   eggNOG; ENOG502RYAR; Eukaryota.
DR   GeneTree; ENSGT00940000157650; -.
DR   HOGENOM; CLU_076370_0_2_1; -.
DR   InParanoid; Q9Z0S5; -.
DR   OMA; FYPGIKY; -.
DR   OrthoDB; 1375597at2759; -.
DR   PhylomeDB; Q9Z0S5; -.
DR   TreeFam; TF331936; -.
DR   BioGRID-ORCS; 60363; 7 hits in 72 CRISPR screens.
DR   ChiTaRS; Cldn15; mouse.
DR   PRO; PR:Q9Z0S5; -.
DR   Proteomes; UP000000589; Chromosome 5.
DR   RNAct; Q9Z0S5; protein.
DR   Bgee; ENSMUSG00000001739; Expressed in small intestine Peyer's patch and 117 other tissues.
DR   Genevisible; Q9Z0S5; MM.
DR   GO; GO:0005923; C:bicellular tight junction; ISS:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0016328; C:lateral plasma membrane; IDA:MGI.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0042802; F:identical protein binding; ISS:UniProtKB.
DR   GO; GO:0005198; F:structural molecule activity; IEA:InterPro.
DR   GO; GO:0070830; P:bicellular tight junction assembly; IBA:GO_Central.
DR   GO; GO:0016338; P:calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules; ISS:UniProtKB.
DR   GO; GO:0007155; P:cell adhesion; IBA:GO_Central.
DR   GO; GO:0006811; P:ion transport; IEA:UniProtKB-KW.
DR   InterPro; IPR006187; Claudin.
DR   InterPro; IPR008094; Claudin15.
DR   InterPro; IPR017974; Claudin_CS.
DR   InterPro; IPR004031; PMP22/EMP/MP20/Claudin.
DR   PANTHER; PTHR12002; PTHR12002; 1.
DR   Pfam; PF00822; PMP22_Claudin; 1.
DR   PRINTS; PR01718; CLAUDIN15.
DR   PROSITE; PS01346; CLAUDIN; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cell junction; Cell membrane; Disulfide bond; Ion transport;
KW   Lipoprotein; Membrane; Palmitate; Phosphoprotein; Reference proteome;
KW   Tight junction; Transmembrane; Transmembrane helix; Transport.
FT   CHAIN           1..227
FT                   /note="Claudin-15"
FT                   /id="PRO_0000144772"
FT   TOPO_DOM        1
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000269|PubMed:24744376"
FT   TRANSMEM        2..24
FT                   /note="Helical"
FT   TOPO_DOM        25..74
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000269|PubMed:24744376"
FT   TRANSMEM        75..99
FT                   /note="Helical"
FT   TOPO_DOM        100..115
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000269|PubMed:24744376"
FT   TRANSMEM        116..140
FT                   /note="Helical"
FT   TOPO_DOM        141..159
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000269|PubMed:24744376"
FT   TRANSMEM        160..182
FT                   /note="Helical"
FT   TOPO_DOM        183..227
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000269|PubMed:24744376"
FT   REGION          146..147
FT                   /note="Important for the formation of tight-junction
FT                   strand-like structures"
FT   SITE            55
FT                   /note="Important for Na(+)-selective paracellular ion
FT                   transport"
FT                   /evidence="ECO:0000250"
FT   SITE            64
FT                   /note="Important for Na(+)-selective paracellular ion
FT                   transport"
FT                   /evidence="ECO:0000250"
FT   SITE            68
FT                   /note="Important for the formation of tight-junction
FT                   strand-like structures"
FT   MOD_RES         111
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P56746"
FT   MOD_RES         211
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:D3ZQJ0"
FT   MOD_RES         214
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         217
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   DISULFID        52..62
FT                   /evidence="ECO:0000269|PubMed:24744376"
FT   MUTAGEN         68
FT                   /note="M->A,E: Abolishes formation of tight-junction
FT                   strand-like structures."
FT                   /evidence="ECO:0000269|PubMed:24744376"
FT   MUTAGEN         68
FT                   /note="M->I,L: No effect on formation of tight-junction
FT                   strand-like structures."
FT                   /evidence="ECO:0000269|PubMed:24744376"
FT   MUTAGEN         102
FT                   /note="C->A: Abolishes palmitoylation; when associated with
FT                   183-A--A-185."
FT                   /evidence="ECO:0000269|PubMed:24744376"
FT   MUTAGEN         146..147
FT                   /note="FF->AA: Abolishes formation of tight-junction
FT                   strand-like structures."
FT                   /evidence="ECO:0000269|PubMed:24744376"
FT   MUTAGEN         183..185
FT                   /note="CCC->AAA: Abolishes palmitoylation; when associated
FT                   with A-102."
FT                   /evidence="ECO:0000269|PubMed:24744376"
FT   CONFLICT        2
FT                   /note="S -> L (in Ref. 1; BAB25544)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        212
FT                   /note="D -> N (in Ref. 1; BAB25544)"
FT                   /evidence="ECO:0000305"
FT   HELIX           2..24
FT                   /evidence="ECO:0007829|PDB:4P79"
FT   STRAND          29..32
FT                   /evidence="ECO:0007829|PDB:4P79"
FT   STRAND          43..46
FT                   /evidence="ECO:0007829|PDB:4P79"
FT   STRAND          48..54
FT                   /evidence="ECO:0007829|PDB:4P79"
FT   STRAND          60..64
FT                   /evidence="ECO:0007829|PDB:4P79"
FT   HELIX           67..72
FT                   /evidence="ECO:0007829|PDB:4P79"
FT   HELIX           75..99
FT                   /evidence="ECO:0007829|PDB:4P79"
FT   STRAND          100..102
FT                   /evidence="ECO:0007829|PDB:4P79"
FT   HELIX           110..146
FT                   /evidence="ECO:0007829|PDB:4P79"
FT   STRAND          156..158
FT                   /evidence="ECO:0007829|PDB:4P79"
FT   HELIX           160..184
FT                   /evidence="ECO:0007829|PDB:4P79"
SQ   SEQUENCE   227 AA;  24280 MW;  7112FE8A6EEF2941 CRC64;
     MSVAVETFGF FMSALGLLML GLTLSNSYWR VSTVHGNVIT TNTIFENLWY SCATDSLGVS
     NCWDFPSMLA LSGYVQGCRA LMITAILLGF LGLFLGMVGL RCTNVGNMDL SKKAKLLAIA
     GTLHILAGAC GMVAISWYAV NITTDFFNPL YAGTKYELGP ALYLGWSASL LSILGGICVF
     STCCCSSKEE PATRAGLPYK PSTVVIPRAT SDESDISFGK YGKNAYV
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024